$1m dollar dementia grant doubled for game-changing research

Wednesday, 12 December 2018 - 10:49am

The Dementia Australia Research Foundation, with the Yulgilbar Alzheimer’s Research Program (YARP), have announced three, rather than one, recipients of its inaugural $1 Million Dollar Innovation Grant for new research ideas that advance dementia research.

Improved brain scans now possible thanks to Australian researcher

Thursday, 12 July 2018 - 2:44pm

An Australian researcher has developed a new technique for developing brain scans with improved accuracy and speed, while providing a less invasive experience for volunteers. These factors combined have the potential to add significant capacity to the field of dementia research.

Funding supports Australia’s best and brightest dementia researchers

Tuesday, 20 March 2018 - 1:18pm

The use of song-writing to improve the relationships between people living with dementia and their families is just one of 17 new projects that will share in more than $1 million in grants to conduct ground-breaking dementia research.

Welcome to the Dementia Australia Research Foundation

Tuesday, 24 October 2017 - 3:31am

We are proud to announce our new name, the Dementia Australia Research Foundation.

2017 Dementia Grants Program - Round 2 CLOSED

Monday, 11 September 2017 - 11:54am

The Alzheimer’s Australia Dementia Research Foundation (AADRF) is pleased to announce the Dementia Grants Program – Round 2 is open 4 September 2017, with four PhD Scholarships of $30,000 per year over three years on offer. **Applications closed 16 October 2017**

New study on dementia awareness to help tackle stigma

Friday, 14 July 2017 - 11:02am

A new program aimed at reducing public stigma associated with dementia is being developed by ANU researcher and recipient of the 2016 Alzheimer’s Australia Hazel Hawke Research Grant in Dementia Care, Dr Sarang Kim.

Ultrasound to boost Alzheimer’s treatment

Thursday, 18 May 2017 - 1:27pm

An Australian research team funded by the AADRF, have recently discovered a feasible treatment for Alzheimer’s disease and frontotemporal dementia, as well as a way of enhancing the delivery of this treatment.